Hyperfine Inc (HYPR)

$1.99

-0.06

(-2.93%)▲

Market is closed - opens 7 PM, 03 Oct 2023

Insights on Hyperfine Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.42M → 3.38M (in $), with an average increase of 34.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 7 quarters, -26.08M → -10.63M (in $), with an average increase of 18.5% per quarter

Performance

  • $1.98
    $2.07
    $1.99
    downward going graph

    0.5%

    Downside

    Day's Volatility :4.35%

    Upside

    3.86%

    downward going graph
  • $0.68
    $3.28
    $1.99
    downward going graph

    65.83%

    Downside

    52 Weeks Volatility :79.27%

    Upside

    39.33%

    downward going graph

Returns

PeriodHyperfine IncSector (Health Care)Index (Russel 2000)
3 Months
-5.53%
-2.2%
0.0%
6 Months
45.39%
-1.7%
-1.8%
1 Year
120.93%
4.2%
3.5%
3 Years
-80.12%
23.6%
14.9%

Highlights

Market Capitalization
145.5M
Book Value
$1.45
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.71
Wall Street Target Price
2.95
Profit Margin
0.0%
Operating Margin TTM
-527.56%
Return On Assets TTM
-23.53%
Return On Equity TTM
-38.63%
Revenue TTM
9.8M
Revenue Per Share TTM
0.14
Quarterly Revenue Growth YOY
120.5%
Gross Profit TTM
907.0K
EBITDA
-50.6M
Diluted Eps TTM
-0.71
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.64
EPS Estimate Next Year
-0.66
EPS Estimate Current Quarter
-0.16
EPS Estimate Next Quarter
-0.16

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 48.24%

Current $1.99
Target $2.95

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hyperfine Inc
Hyperfine Inc
-0.49%
45.39%
120.93%
-80.12%
-79.52%
Stryker Corporation
Stryker Corporation
-4.55%
-4.97%
30.23%
27.66%
55.88%
Boston Scientific Corp.
Boston Scientific Corp.
-0.94%
6.19%
32.4%
34.56%
36.75%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-8.81%
-15.69%
-18.93%
-12.09%
28.22%
Abbott Laboratories
Abbott Laboratories
-3.99%
-4.67%
-2.68%
-10.79%
34.44%
Medtronic Plc
Medtronic Plc
-2.29%
-1.64%
-5.25%
-23.15%
-20.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hyperfine Inc
Hyperfine Inc
NA
NA
NA
-0.64
-0.39
-0.24
0.0
1.45
Stryker Corporation
Stryker Corporation
38.6
38.6
2.85
10.36
0.16
0.06
0.01
45.71
Boston Scientific Corp.
Boston Scientific Corp.
90.46
90.46
2.53
2.0
0.05
0.04
0.0
12.46
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
31.09
31.09
3.07
2.55
0.22
0.12
0.0
10.49
Abbott Laboratories
Abbott Laboratories
33.49
33.49
18.76
4.39
0.14
0.06
0.02
21.42
Medtronic Plc
Medtronic Plc
29.04
29.04
3.04
5.28
0.07
0.04
0.04
38.47
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hyperfine Inc
Hyperfine Inc
NA
$145.5M
-79.52%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$103.8B
55.88%
38.6
13.92%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$78.1B
36.75%
90.46
6.81%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$42.5B
28.22%
31.09
24.56%
Abbott Laboratories
Abbott Laboratories
Buy
$170.3B
34.44%
33.49
12.83%
Medtronic Plc
Medtronic Plc
Buy
$104.7B
-20.86%
29.04
11.47%

Institutional Holdings

  • Vanguard Group Inc

    2.93%

  • Fosun International Ltd

    2.44%

  • Avidity Partners Management LP

    1.67%

  • Alphabet Inc

    1.26%

  • BlackRock Inc

    1.00%

  • EAM Investors, LLC

    0.76%

Corporate Announcements

  • Hyperfine Inc Earnings

    Hyperfine Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

hyperfine’s mission is to make mri accessible to every patient, regardless of income or resources. anytime. anywhere.hyperfine’s swoop® portable mr imaging system™ addresses limitations of current imaging technologies. swoop wheels directly to a patient’s bedside, where it plugs into a standard electrical outlet and uses an apple ipad® for control. images display within minutes, enabling critical decision-making capabilities across various clinical settings such as neurointensive care units, emergency departments, pediatrics, and more. designed as a complementary system to fixed conventional mri systems, new users can be trained on system operation, device navigation, and safety in about 30 minutes, helping clinicians streamline workflow. the complete swoop™ portable mr imaging system costs less than the annual service contract for most fixed conventional mri systems.in august 2020, swoop received market-ready fda clearance for portable mr imaging of the brain and head for patients of

Organization
Hyperfine Inc
Employees
136
CEO
Mr. R. Scott Huennekens CPA, M.B.A.
Industry
Healthcare

Discover More

FAQs